Skip to main content

Dx Focus: HiberGene Diagnostics Begins Manufacturing for Meningitis MDx Test

Premium

Ireland's HiberGene Diagnostics said this week that it has begun manufacturing its molecular diagnostic test for meningococcal meningitis.

HiberGene, based in Dublin, is a startup company of NovaUCD, an innovation and technology transfer center. The company licensed its meningitis test from Belfast Health and Social Care Trust.

HiberGene's test is based on loop-mediated isothermal amplification. According to the company's website, the test can be performed in less than 40 minutes, is 100 percent sensitive and 99.7 percent specific, and requires minimal laboratory instrumentation.

The company said it is also developing a molecular diagnostic test for pneumococcal meningitis using the same technology.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.